CLINICAL_TRIALS
trial_result
· 2017-08-04
Clinical Trial Update: A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer [Phase 2]
Summary
Phase 2 trial evaluating Bevacizumab (Avastin) in newly diagnosed locally advanced rectal cancer completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-08-04